Salta al contenuto principale
Attendere prego...

Home

  • CANDIOLO CANCER INSTITUTE - IRCCS
    Today's Science
    Tomorrows's Medicine
The interface between Traslational Research and Clinical Practice is at the core of the Institute.

Research Activities

Capitalizing on this wealth of information, Traslational and Clinical Research are now revolutionizing the way we diagnose and treat cancer and offers unprecedented opportunities to improve the outlook of cancer patients on a rational basis.

Traslational Research

  • Cancer Mtabolism
  • Tumor Microenvironment
  • Cell Adhesion Dynamics
  • Cell Migration
  • Membrane Traffic
  • Vascular Oncology
  • Neurovascular Biology

Experimental Clinincal Molecular Oncology

  • Molecular Therapeutics and Exploratory Research
  • Molecular Oncology
  • Cancer Genetics
  • Oncogenomics
  • Cancer Epigenetics
  • Cancer Molecular Biology
  • Cancer Sem Cell Research
  • Traslational Cencer Medicine
  • Experimental Cell Therapy
  • Gene Transfer
  • Metabolic Dynamics in Cancer

Investigational Clinical Oncology

  • Breast Cancer
  • Cancer of Unknown Primary

Clinical Research

  • Medical Oncology
  • Clinical Cell Therapy
  • Sarcoma
  • Gynecological Oncology
  • Surgical Oncology
  • Gastrointestinal Cancer
  • Ovarian Cancer
  • Pathology
  • Imaging
  • Nuclear Medicine-PET
  • Radiation Therapy
Istituto di Ricerca e Cura a Carattere Scientifico

The Candiolo Cancer Institute

The Candiolo Cancer Institute is a private non-profit institution founded and supported by the Fondazione Piemontese per la Ricerca sul Cancro-Onlus (FPRC) and operated by the Fondazione del Piemonte per l’Oncologia (FPO: co-founded by FPRC and the Regione Piemonte). The Institute is a recognized IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) by the Italian Ministry of Health. The Candiolo Cancer Institute works in synergy with the University of Torino Medical School. Its mission is a significant contribution to fight cancer, by understanding the basics, and by providing state-of-the-art diagnostic and therapeutic services. The interface between molecular biology and medicine is at the core of the Institute. FPRC provides enduring fund raising to complete and develop the Institute’s buildings and technologies in order to foster research.

Research

1589 Scientific Pubblications

Admissions

7813 Admissions

Clinical - Human Resources

530 Staff

Research - Human Resources

323 Staff

About

The Candiolo Cancer Institute is a private non-profit institution founded and supported by the Fondazione Piemontese per la Ricerca sul Cancro-Onlus (FPRC) and operated by the Fondazione del Piemonte per l’Oncologia (FPO: co-founded by FPRC and the Regione Piemonte).